Abstract
Introduction: Alcoholic Cardiomyopathy (ACM) is a disease with a difficult diagnosis. The real mechanisms related to its pathophysiology are not fully understood.
Objective: The aims of this study were to investigate whether miR-133b and miR-138 could be associated with ACM.
Methods: Forty-four patients were included comprising 24 with ACM and 20 with cardiomyopathies of different etiologies (control group). Real-time PCR was performed to verify the relative expression among the studied groups. In the statistical analysis, the quantitative variables t-student Mann- Whitney and correlation of Pearson tests were carried out, while the qualitative variable comprised the chi-square test, with p<0.05 being considered statistically significant.
Results: There was no association between clinical and sociodemographic characteristics of the groups. The patients with ACM presented downregulation of miR-133b in comparison with control patients (p=0.004). On the other hand, for the miR-138, there was no association when the ACM group was compared with the control group. The presence of miR-133b among cases and controls was not correlated with any of the echocardiographic parameters. However, the increase in the expression of miR-138 was correlated with an increase in the ejection fraction (r=0.28, p=0.01) and the diameter of the left atrium (r=0.23, p=0.04) in patients with ACM.
Conclusion: The downregulation of miR-133b might be a marker for ACM and, in addition, miR- 138 could be used to correlate the increase in ejection fraction with and normalization of the diameter of the left atrium diameter in patients with this disease.
Keywords: Alcoholic cardiomyopathy, biomarkers, cardiomegaly, echocardiography, fibrosis, microRNA.
Graphical Abstract
[http://dx.doi.org/10.1016/j.biocel.2017.06.009] [PMID: 28606389]
[http://dx.doi.org/10.1007/s00059-016-4463-z] [PMID: 27582366]
[http://dx.doi.org/10.1007/s12012-014-9252-4] [PMID: 24671642]
[http://dx.doi.org/10.2459/JCM.0b013e32833833a3] [PMID: 20308914]
[http://dx.doi.org/10.1111/acer.12109] [PMID: 23527963]
[http://dx.doi.org/10.4330/wjc.v6.i8.771] [PMID: 25228956]
[PMID: 26180810]
[http://dx.doi.org/10.1007/s00109-011-0840-5] [PMID: 22159451]
[http://dx.doi.org/10.1016/j.neuron.2008.05.032] [PMID: 18667155]
[http://dx.doi.org/10.4161/auto.18997] [PMID: 22441020]
[http://dx.doi.org/10.1159/000370028] [PMID: 25791397]
[http://dx.doi.org/10.1007/s12192-016-0760-y] [PMID: 28160209]
[PMID: 28840590]
[http://dx.doi.org/10.1016/j.alcohol.2004.01.005] [PMID: 15282111]
[http://dx.doi.org/10.3233/JAD-180940] [PMID: 30909216]
[http://dx.doi.org/10.3892/mmr.2016.5769] [PMID: 27665963]
[http://dx.doi.org/10.3892/ijo.2016.3317] [PMID: 26782922]
[http://dx.doi.org/10.2174/187152061401140108113435] [PMID: 23438844]
[PMID: 29257301]
[http://dx.doi.org/10.3892/or.2018.6389] [PMID: 29693184]
[http://dx.doi.org/10.1371/journal.pone.0052442] [PMID: 23300973]
[http://dx.doi.org/10.3892/or.2018.6215] [PMID: 29344640]
[http://dx.doi.org/10.3892/or.2017.5699] [PMID: 28586051]
[PMID: 29786744]
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.08.009] [PMID: 28939047]
[http://dx.doi.org/10.1016/j.bbadis.2016.08.009] [PMID: 27544699]
[http://dx.doi.org/10.1016/j.ijcard.2014.05.019] [PMID: 24910366]
[http://dx.doi.org/10.1177/1535370214546268] [PMID: 25125495]
[http://dx.doi.org/10.1016/j.taap.2015.11.015] [PMID: 26627004]
[http://dx.doi.org/10.3892/mmr.2016.5977] [PMID: 27922664]
[http://dx.doi.org/10.1093/cvr/cvp130] [PMID: 19398468]
[http://dx.doi.org/10.1038/clpt.2013.138] [PMID: 23852395]
[http://dx.doi.org/10.1002/jcp.22322] [PMID: 20635395]
[http://dx.doi.org/10.1161/CIRCRESAHA.108.182535] [PMID: 19096030]
[http://dx.doi.org/10.1002/jcp.25934] [PMID: 28369910]
[http://dx.doi.org/10.2337/db12-0533] [PMID: 23223177]
[http://dx.doi.org/10.1042/BJ20120680] [PMID: 23485012]
[http://dx.doi.org/10.1177/1535370215591831] [PMID: 26129883]
[http://dx.doi.org/10.1016/j.bbrc.2013.10.151] [PMID: 24211202]